News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
709,279 Results
Type
Article (41587)
Company Profile (264)
Press Release (667428)
Section
Business (207942)
Career Advice (2038)
Deals (35880)
Drug Delivery (96)
Drug Development (82502)
Employer Resources (170)
FDA (16348)
Job Trends (15076)
News (351304)
Policy (33081)
Tag
Academia (2642)
Alliances (50436)
Alzheimer's disease (1347)
Approvals (16335)
Artificial intelligence (226)
Bankruptcy (362)
Best Places to Work (11812)
Biotechnology (187)
Breast cancer (234)
Cancer (1803)
Cardiovascular disease (135)
Career advice (1701)
CAR-T (132)
Cell therapy (378)
Clinical research (66353)
Collaboration (716)
Compensation (395)
COVID-19 (2618)
C-suite (179)
Data (1723)
Diabetes (223)
Diagnostics (6395)
Earnings (87113)
Employer resources (146)
Events (114032)
Executive appointments (611)
FDA (17322)
Funding (646)
Gene therapy (265)
GLP-1 (665)
Government (4448)
Healthcare (19238)
Infectious disease (2739)
Interviews (316)
IPO (16614)
Job creations (3704)
Job search strategy (1450)
Layoffs (449)
Legal (8036)
Lung cancer (261)
Manufacturing (248)
Medical device (13413)
Medtech (13418)
Mergers & acquisitions (19665)
Metabolic disorders (581)
Neuroscience (1782)
NextGen: Class of 2025 (6659)
Non-profit (4595)
Northern California (2222)
Obesity (316)
Opinion (199)
Patents (177)
People (57977)
Phase I (20699)
Phase II (29169)
Phase III (21732)
Pipeline (806)
Postmarket research (2650)
Preclinical (9004)
Radiopharmaceuticals (247)
Rare diseases (344)
Real estate (6042)
Regulatory (22375)
Research institute (2430)
Resumes & cover letters (354)
Southern California (1902)
Startups (3647)
United States (19717)
Vaccines (629)
Weight loss (216)
Date
Today (221)
Last 7 days (865)
Last 30 days (2953)
Last 365 days (35022)
2025 (5682)
2024 (35790)
2023 (40532)
2022 (51742)
2021 (56314)
2020 (54805)
2019 (47489)
2018 (35754)
2017 (32676)
2016 (32260)
2015 (38357)
2014 (32048)
2013 (27138)
2012 (29438)
2011 (30048)
2010 (28279)
Location
Africa (746)
Arizona (217)
Asia (38380)
Australia (6272)
California (5063)
Canada (1764)
China (418)
Colorado (233)
Connecticut (249)
Europe (83661)
Florida (753)
Georgia (172)
Illinois (474)
Indiana (277)
Japan (128)
Maryland (774)
Massachusetts (3879)
Michigan (201)
Minnesota (349)
New Jersey (1463)
New York (1453)
North Carolina (966)
Northern California (2222)
Ohio (178)
Pennsylvania (1150)
South America (1123)
Southern California (1902)
Texas (738)
Utah (156)
Washington State (485)
709,279 Results for "model n inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Fangzhou Inc. integrates DeepSeek open-source AI Model to enhance Internet healthcare
February 18, 2025
·
3 min read
Deals
Model N to be Acquired by Vista Equity Partners For $1.25 Billion
Model N announced that it has entered into a definitive agreement to be acquired by Vista Equity Partners, a leading global investment firm focused exclusively on enterprise software, data, and technology-enabled businesses.
April 8, 2024
·
10 min read
Drug Development
A Novel Broad-Spectrum Antiviral Against Influenza A Viruses, NV-387, Is Effective in Protecting Lungs from Damage in Lethally Infected Animal Model
NanoViricides, Inc. reports that the ultra-broad-spectrum antiviral NV-387, a clinical Phase II stage drug candidate, was found to be effective in protecting lungs from damage in a lethally infected Influenza A H3N2 mouse model.
June 20, 2024
·
10 min read
Business
Model N Announces Date of Fourth Quarter and Fiscal Year 2023 Financial Results
Model N, Inc., the leader in revenue optimization and compliance, plans to announce financial results for the fourth quarter and fiscal year 2023 after market close on Thursday, November 9, 2023.
October 19, 2023
·
1 min read
Business
Model N Responds to Mounting Regulatory Pharma Pressures with Innovations that Ensure Compliance and Optimize Revenue
Model N, the leader in revenue optimization and compliance announced new product innovations geared towards the increasingly complex regulatory environment for global pharma manufacturers.
November 7, 2023
·
4 min read
Press Releases
Traws Pharma Reports Positive Results from An Accepted Bird Flu Model for Anti-Viral Candidate, Tivoxavir Marboxil
March 4, 2025
·
5 min read
Press Releases
IGC Pharma Expands AI Platform With Advanced Diagnostic Model for Alzheimer’s and Dementia Detection
March 4, 2025
·
4 min read
Press Releases
Tevogen Bio’s Business Model Addresses Biopharma Industry Challenges with Cost-Efficient Innovation
February 11, 2025
·
5 min read
Press Releases
JuliaHub Doubles Investment in Advanced Pharmaceutical Modeling Platform
February 12, 2025
·
1 min read
Business
Model N Announces Third Quarter Fiscal Year 2023 Financial Results
Model N, Inc., the leader in cloud revenue management solutions, announced financial results for the third quarter of fiscal year 2023 ended June 30, 2023.
August 8, 2023
·
22 min read
1 of 70,928
Next
